Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Powers

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Science (New York, N.Y.)|March 3, 2009
A transposon-based genetic screen in mice identifies genes altered in colorectal cancerTimothy K Starr, Raha Allaei, Kevin A T Silverstein, et al.
The Journal of Cell Biology|February 15, 2017
The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN proteinMuhan Chen, Dawid G Nowak, Navneet Narula, et al.
Nature Reviews. Cancer|January 26, 2020
A framework for advancing our understanding of cancer-associated fibroblastsErik Sahai, Igor Astsaturov, Edna Cukierman, et al.
Nature Biotechnology|September 11, 2010
Towards patient-based cancer therapeutics, Stuart L Schreiber, Alykhan F Shamji, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Science (New York, N.Y.)|March 3, 2009
A transposon-based genetic screen in mice identifies genes altered in colorectal cancerTimothy K Starr, Raha Allaei, Kevin A T Silverstein, et al.
The Journal of Cell Biology|February 15, 2017
The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN proteinMuhan Chen, Dawid G Nowak, Navneet Narula, et al.
Nature Reviews. Cancer|January 26, 2020
A framework for advancing our understanding of cancer-associated fibroblastsErik Sahai, Igor Astsaturov, Edna Cukierman, et al.
Nature Biotechnology|September 11, 2010
Towards patient-based cancer therapeutics, Stuart L Schreiber, Alykhan F Shamji, et al.
Pageof 10